FDA approves new treatment for late-onset Pompe disease.
D000328:Adult; D017668:Age of Onset; D017277:Drug Approval; D005260:Female; D006009:Glycogen Storage Disease Type II / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D014481:United States; D014486:United States Food and Drug Administration; D000520:alpha-Glucosidases / Q000494:pharmacology* / Q000627:therapeutic use
D000520:alpha-Glucosidases